Literature DB >> 21736531

Long-term follow-up of a randomized controlled trial of observation versus surgery for acute cholecystitis: non-operative management is an option in some patients.

Malte Schmidt1, Karl Søndenaa, Morten Vetrhus, Tewelde Berhane, Geir Egil Eide.   

Abstract

BACKGROUND: Cholecystectomy is routinely recommended to prevent recurrent disease after an initial episode of acute cholecystitis. Therefore, randomized controlled trials have mainly focused on the timing of surgery, but many patients scheduled for cholecystectomy have deferred surgery with long periods of symptom-free intervals. Our present aim is to examine the long-term feasibility and safety of observation compared with surgery.
METHODS: Trial of 64 patients with acute cholecystitis previously randomized to observation or cholecystectomy, which examined outcome in terms of completed randomized treatment and appearance of further symptoms and the need for surgical treatment. Thirty-three patients were randomized to observation and 31 patients to cholecystectomy. Median follow-up was 14 years.
RESULTS: Of the 33 patients randomized to observation, 11 (33%) experienced a new event of gallstone-related disease (eight (24.2%) had acute cholecystitis) and 11 (33%) were operated. No significant difference (p = 0.565) was found between the two randomized groups with regard to recurrent disease or complications. Virtually no surgery took place after 5 years of follow-up. The difference in completed randomized treatment between the groups was not significant (p = 0.077). Long-term mortality was equal in those operated and in those observed.
CONCLUSIONS: Twenty-four percent of the patients experienced recurrent cholecystitis, but escalation of disease severity or increased mortality was not observed. Long-term observation after acute cholecystitis was feasible in two-thirds of the patients as the risk for recurrent disease was negligible after 5 years.

Entities:  

Mesh:

Year:  2011        PMID: 21736531     DOI: 10.3109/00365521.2011.598548

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  How Do Quality-of-Life and Gastrointestinal Symptoms Differ Between Post-cholecystectomy Patients and the Background Population?

Authors:  Viktor Wanjura; Gabriel Sandblom
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

2.  Evidence-based treatment of gallstone disease.

Authors:  Karl Søndenaa
Journal:  J Gastrointest Surg       Date:  2013-12       Impact factor: 3.452

Review 3.  Surgical management of acute cholecystitis.

Authors:  Rahul S Koti; Christopher J Davidson; Brian R Davidson
Journal:  Langenbecks Arch Surg       Date:  2015-05-14       Impact factor: 3.445

Review 4.  Acute cholecystitis.

Authors:  Valerie Halpin
Journal:  BMJ Clin Evid       Date:  2014-08-20

5.  High rates of recurrence of gallstone associated episodes following acute cholecystitis during long term follow-up: a retrospective comparative study of patients who did not receive surgery.

Authors:  Chovav Handler; Uri Kaplan; Dan Hershko; Ossama Abu-Hatoum; Doron Kopelman
Journal:  Eur J Trauma Emerg Surg       Date:  2022-10-05       Impact factor: 2.374

Review 6.  Conservative treatment of acute cholecystitis: a systematic review and pooled analysis.

Authors:  Charlotte S Loozen; Jelmer E Oor; Bert van Ramshorst; Hjalmar C van Santvoort; Djamila Boerma
Journal:  Surg Endosc       Date:  2016-06-17       Impact factor: 4.584

Review 7.  Systematic review of the clinical and cost effectiveness of cholecystectomy versus observation/conservative management for uncomplicated symptomatic gallstones or cholecystitis.

Authors:  Miriam Brazzelli; Moira Cruickshank; Mary Kilonzo; Irfan Ahmed; Fiona Stewart; Paul McNamee; Andy Elders; Cynthia Fraser; Alison Avenell; Craig Ramsay
Journal:  Surg Endosc       Date:  2014-08-14       Impact factor: 4.584

8.  Percutaneous cholecystostomy in acute cholecystitis; a retrospective analysis of a large series of 104 patients.

Authors:  Asgaut Viste; Dag Jensen; Jon Helge Angelsen; Dag Hoem
Journal:  BMC Surg       Date:  2015-03-08       Impact factor: 2.102

Review 9.  2016 WSES guidelines on acute calculous cholecystitis.

Authors:  L Ansaloni; M Pisano; F Coccolini; A B Peitzmann; A Fingerhut; F Catena; F Agresta; A Allegri; I Bailey; Z J Balogh; C Bendinelli; W Biffl; L Bonavina; G Borzellino; F Brunetti; C C Burlew; G Camapanelli; F C Campanile; M Ceresoli; O Chiara; I Civil; R Coimbra; M De Moya; S Di Saverio; G P Fraga; S Gupta; J Kashuk; M D Kelly; V Koka; H Jeekel; R Latifi; A Leppaniemi; R V Maier; I Marzi; F Moore; D Piazzalunga; B Sakakushev; M Sartelli; T Scalea; P F Stahel; K Taviloglu; G Tugnoli; S Uraneus; G C Velmahos; I Wani; D G Weber; P Viale; M Sugrue; R Ivatury; Y Kluger; K S Gurusamy; E E Moore
Journal:  World J Emerg Surg       Date:  2016-06-14       Impact factor: 5.469

10.  Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study.

Authors:  Lih-Yu Chang; Chih-Hsin Lee; Chia-Hao Chang; Ming-Chia Lee; Meng-Rui Lee; Jann-Yuan Wang; Li-Na Lee
Journal:  BMC Infect Dis       Date:  2018-02-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.